Customize
Quick Links

Accreditation/
Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgement of Commercial Support This activity is supported by an educational grant from Novocure.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

Medical Crossfire®: Overcoming Clinical Inertia in Glioblastoma Multiforme: The Experts Weigh-In on Recent Data Sets and Next Steps to Move the Field Forward

Medical Crossfire®: Overcoming Clinical Inertia in Glioblastoma Multiforme: The Experts Weigh-In on Recent Data Sets and Next Steps to Move the Field Forward


Sunday, October 21, 2018
7:00 PM – 9:00 PM
Dinner and registration: 6:30 PM – 7:00 PM

Grand Hyatt San Antonio, Texas Ballroom C
600 E Market St.
San Antonio, TX 78205
 

Overview:

Although there have been recent advancements in the understanding of the pathophysiology of glioblastoma multiforme (GBM), as well as modest improvements in its treatment, the overall prognosis for patients with GBM remains poor. While clinical interest in new treatment options to help improve outcomes for these patients is high, the development and incorporation of new technologies and targeted therapies into the treatment paradigm historically has been challenging.
 
In order to help you increase your understanding of these challenges and provide you with insights into the potential of new technologies—such as Tumor Treating Fields, and novel approaches such as targeted therapies and immunotherapies—to improve patient outcomes, we have developed a dynamic Medical Crossfire® program to share the perspectives of leading clinical experts on the latest data and factors that may change your clinical practice. This exchange of ideas will explore the management of patients with GBM in both the newly diagnosed and recurrent settings, giving you the opportunity to assess the opinions of multidisciplinary experts and optimize your approach to challenging, real-world clinical scenarios.

Target Audience

This education program is directed towards radiation oncologists, researchers, and other oncology healthcare professionals interested in the treatment of GBM. 

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novocure.

Learning Objectives

  • Describe the therapeutic rationale for the use of technology and emerging treatment options in the management of patients with GBM
  • Evaluate safety and efficacy outcomes from recent clinical trials of treatment for GBM
  • Develop evidence-based strategies to optimize clinical application of recent data on targeted therapies, immunotherapies, and technology for patients with GBM
  • Identify challenges associated with the current clinical trials landscape for patients with GBM

Activity Co-Chairs

Roger Stupp, MD
Chief of Neuro-oncology in the Department of Neurology
Professor of Neurological Surgery, Medicine (Hematology and Oncology) and Neurology (Neuro-oncology)
Feinberg School of Medicine
Chicago, IL

Erik P. Sulman, MD, PhD
Interim Member of the Faculty, Department of Radiation Oncology
NYU School of Medicine
New York, NY
 







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By